Nicotinic Acid in the Treatment of Schizophrenias: Canadian Mental Health Association Collaborative Study Progress Report II *

Ananth J. V. , Ban T. A. , Lehmann H. E. , and Bennett Jean : Nicotinic acid in the prevention and treatment of methionineinduced exacerbation of psychopathology in schizophrenic patients. Can. Psychiat. Assoc. J. 15: 15–19, 1970.

Ananth J. V. , Vacaflor L. , Kekhwa G. , Sterlin C. , and Ban T. A. : Nicotinic acid in the treatment of newly admitted schizophrenic patients: A placebo controlled study. Int. J. Clin. Pharmacology 5: 406–410, 1972.

Ban T. A. : Niacin in the treatment of schizophrenias. Psychopharmacol. Bull. 5: 5–20, 1969.

Ban T. A. : Nicotinic acid in the treatment of schizophrenias. Introduction. Canadian Mental Health Association, Toronto, 1971.

Ban T. A. : Nicotinic acid in the treatment of schizophrenias. Complementary Report A. Canadian Mental Health Association, Toronto, 1971.

Ban T. A. , and Lehmann H. E. : Nicotinic acid in the treatment of schizophrenias. Progress Report I. Canadian Mental Health Association, Toronto, 1970.

Ban T. A. , Lehmann H. E. , and Klingner A. : Nicotinic acid and catechol-O-methyltransferase activity in schizophrenia. Int. J. Clin. Pharmacol. Therap. and Toxicology 7: 44–47, 1973.

Deutsch M. , Ananth J. V. , Ban T. A. , Lehmann H. E. , and Klingner A. : Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: A placebo-controlled clinical study (in press 1973).

Ellerbrook R. C. , and Purdy M. D. : Capacity of stressed humans under megadoses of nicotinic acid to synthesize methylated compounds. Dis. Nerv. Syst. 31: 196–197, 1970.

Feldstein A. : Biochemical Aspects of Schizophrenia and Antipsychotic Drugs. In: Dimascio A. , and Shader R. Eds.: Handbook of Psychopharmacology. New York, Science House, 1970.

Friedhoff A. J. , and Van Winkle E. : Isolation and characterization of a compound from the urine of schizophrenics. Nature 194: 897–898, 1962.

Green D. E. , and Richter D. : Adrenalin and adrenochrome. Biochemical J. 31: 596–616, 1937.

Harley-Mason J. : In: Osmond H. , and Smythies J. R. : Schizophrenia: A new approach. J. Ment. Sci. 98: 309–315, 1952.

Hoffer A. : Niacin Therapy in Psychiatry. Springfield, Charles C. Thomas, 1962.

Hoffer A. , Osmond H. , Callbeck M. J. , and Kahan I. : Treatment of schizophrenia with nicotinic acid and nicotinamide. J. Clin. Exper. Psychopathology 18: 131–157, 1957.

Hoffer A. , and Kenyon M. : Conversion of adrenalin to adrenolutin in human blood serum. A.M.A. Arch. Neurol. Psychiatry 77: 437–438, 1957.

Hoffer A. , Osmond H. , and Smythies J. R. : Schizophrenia: A new approach. J. Ment. Sci. 100: 29–54, 1954.

Kety S. S. : Current biochemical approaches to schizophrenia. New England J. Med. 276: 325–331, 1967.

Noteboom L. : Experimental catatonia by means of derivatives of mescaline and adrenaline. Proc. Adad. Sciences 37: 562–565, 1934.

Osmond H. , and Smythies J. R. : Schizophrenia: A new approach. J. Ment. Sci. 98: 309–315, 1952.

Overall J. E. , and Gorham D. R. : The brief psychiatric rating scale. Psychol. Rep. 10: 799–805, 1962.

Pauling L. : Orthomolecular psychiatry. Science 160: 265–271, 1968.

Price J. : Methylation in schizophrenics: A pharmacogenetic study. J. Psychiat. Res. 9: 345–351, 1972.

Ramsay R. A. , Ban T. A. , Lehmann H. E. , Saxena B. M. , and Bennett Jean : Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients. Can. Med. Assoc. J. 102: 939–942, 1970.

Wittenborn J. R. : Niacin in the long-term treatment of schizophrenias. Arch. Gen. Psychiatry 28: 308–315, 1973.